Gangliosides shed by tumor cells are immunosuppressive molecules, but
the mechanisms of shedding are poorly understood. We therefore conduct
ed a comprehensive study of shedding to identify the natural forms of
shed gangliosides. By chemical detection and mass spectrometric analys
is of the gangliosides of YAC-1 murine lymphoma cells, we first confir
med that all major ganglioside species are released. Then, by the comb
ination of metabolic and cell surface radiolabeling, we further demons
trated that gangliosides are released directly from the cell plasma me
mbrane, i.e. by shedding. Ultracentrifugation separated the conditione
d medium of metabolically radiolabeled cells cultured in either serum-
free or serum-containing medium into: (1) a pellet of 100-200 nm membr
ane vesicles (visualized by electron microscopy) containing nearly one
-third of total shed gangliosides; and (2) the supernatant, which cont
ained soluble gangliosides (two-thirds of the total shed gangliosides)
. Although the ganglioside concentration in the conditioned medium (6-
14 x 10(-8) M) was above the critical micelle concentration of purifie
d YAC-1 gangliosides (< 1 x 10(-8) M), by gel filtration > 90% of the
soluble gangliosides were found in monomeric form (MW < 2 kDa) and onl
y < 10% in micelles (130 kDa). Ultrafiltration of fresh conditioned me
dium likewise showed the existence of monomers, and the findings were
confirmed in human Daoy medulloblastoma and mouse MEB4 melanoma cells.
Thus, in their natural states, shed tumor cell gangliosides exist in
three forms: membrane vesicles, micelles, and monomers. (C) 1998 Publi
shed by Elsevier Science B.V. All rights reserved.